A-share pharmaceutical company cash dividend list: 8 luxury over 10 billion

Pharmaceutical Network On May 26th, with the a-share listed companies annual report disclosure of the curtain, a number of "Tuhao" pharmaceutical enterprises have also surfaced, in 2019 have launched a grand dividend programAmong them, 36 pharmaceutical enterprises launched a cash dividend scheme of more than 5 yuan, Yunnan White Pharmaceuticals, Step Pharmaceuticals, Lizhu Group, Hengrui Pharmaceuticals, Jichuan Pharmaceuticals and other 8 cash dividends are more than 1 billion yuan, the total cash dividend stakes of more than 10 billion yuanrecently, the Shanghai and Shenzhen exchanges released the 2019 annual report of listed companies analysis reportA total of 2,500 companies disclosed cash dividends in the annual report, the total amount of dividends exceeded 1.30 trillion yuan, a new highAmong them, a total of about 1100 companies in Shanghai launched dividend schemes, accounting for 81% of the total number of profitable companies, the total amount of dividends of 107 million yuanAbout 1459 companies in Shenzhen city launched dividend plans, with dividends amounting to 287.95 billion yuan, up 10.5% year-on-yearIt is worth noting that there are manyhere have also launched a grand dividend schemeA-share pharmaceutical enterprises cash dividend ranking
pharmaceutical enterprises in the luxury of dividends behind, can not be separated from the performance of supportSuch as Hengrui Pharmaceutical's net profit exceeded 5 billion yuan, Zhifei Bio's performance in the past three years, 2017-2019 net profit increased by 1229%, 235.8%, 63.05 percent, respectivelystatistics, 36 pharmaceutical companies launched 10 more than 5 yuan cash dividend program, an increase of 9 in 2018Among them, Yunnan white medicine per 10 distribution of 30 yuan, step-by-step pharmaceutical per 10 shares of 16.14 yuan, Meirui Medical and Sussian biological per 10 shares of 15 yuanIn addition, Zhejiang Medicine, Sunflower Pharmaceuticals, Changchun Gaoxin and other 6 10 shares of 10 yuanIt is worth mentioning that there is no shortage of science and technology board enterprises, there are such as Shushi Biological, Xiangsheng Medical, South Micromedicine and other 5 　　A-share pharmaceutical enterprises in the total cash dividend in the total cash dividend, more than 1 billion yuan of pharmaceutical enterprises have 8, 500 million-1 billion yuan pharmaceutical enterprises have 10 Among them, Yunnan white medicine with 2.832 billion yuan in the first place, step pharmaceutical, Zhejiang medicine and sunflower pharmaceutical dividend ratio of more than 100% Broker analysis pointed out that the cash dividend reached 30% is widely recognized in the market high proportion of the red line, in recent years, the Shanghai and Shenzhen city cash dividend amount and cash dividend rate significantly increased In recent years, under the active guidance of the regulatory authorities, the cash dividends of listed companies have gradually become the norm, the number of companies and the amount of dividends are increasing year by year In addition, long-term non-dividend listed companies will continue to strengthen supervision, thereby promoting listed companies to continuously improve the level of cash dividends source: Oriental Wealth Network, listed companies announcement and other notes: if there are omissions, welcome to point the finger!